Analystreport

Stoke Therapeutics (NASDAQ:STOK) was upgraded by analysts at Weiss Ratings from a "sell (d+)" rating to a "hold (c-)" rating.

Stoke Therapeutics, Inc.  (STOK) 
Last stoke therapeutics, inc. earnings: 11/12 08:00 am Check Earnings Report